Skip to main content
. 2018 Nov 9;6(1):11–16. doi: 10.1002/mdc3.12687

Table 1.

Multisystem involvement in 22q11.2 deletion syndrome

System Examples of Features That May Increase the Index of Suspicion for 22q11.2DS Estimated Prevalence in 22q11.2DS*
Nervous system Neurological
Recurrent seizures, epilepsy16 16%, 4%
Early‐onset PD4 >5%
Parkinsonism not meeting criteria for PD9, 10 To be determined
Other movement disorders (e.g., myoclonic disorders)9, 11, 12, 13 To be determined
Functional neurological disorder6 To be determined
Psychiatric
Attention deficit and hyperactivity disorder (pediatric history)8 >30%
Anxiety disorders8, 17 ∼30%
Schizophrenia8, 17 20% to 25%
Cognitivea
Learning disabilities5 >90%
Intellectual disabilities5 ∼35%
Cognitive deterioration14 To be determined
Sensory system Hearing loss (any type, especially conductive secondary to otitis media)18 6% to 60%
Hyposmia9, 10, 19 >40%
Endocrine system Hypocalcemia20 80%
Obesity21 >40%
Hypothyroidism5 20%
Circulatory system Congenital heart defects requiring surgery5 30% to 40%
Thrombocytopenia (usually mild)5 30%
Respiratory system and related Hypernasal speech or other minor speech impediment5 >90%
Velopharyngeal dysfunction2 15‐30%
Obstructive sleep apnea22 >10%
Skeletal system Scoliosis (usually mild)5 45%
Immune system Recurrent infections (pediatric history)5 35% to 40%
Renal system Structural urinary tract anomaly5 30%
Gastrointestinal system Constipation (common, varying degrees)5 To be determined
Dysmotility/dysphagia (common, varying degrees)5 35%
*

Estimates of lifetime prevalences, all significantly higher than general population estimates, that may vary depending on the age of the patient and ascertainment sources.

a

Note also high variability from person to person.

22q11.2DS, 22q11.2 deletion syndrome.